Volume 17, Number 7,
Issue of April 1, 1997
pp. 2585-2594
Copyright ©1997 Society for Neuroscience
µ-Opioid Receptors Are Localized to Extrasynaptic Plasma
Membranes of GABAergic Neurons and Their Targets in the Rat Nucleus
Accumbens
Received Dec. 9, 1996; revised Jan. 14, 1997; accepted Jan. 16, 1997.
Adena L. Svingos1,
Akiyoshi Moriwaki2,
Jia Bei Wang2,
George R. Uhl2, and
Virginia M. Pickel1
1 Division of Neurobiology, Department of Neurology and
Neuroscience, Cornell University Medical Center, New York, New York
10021, and 2 Intramural Research Program, National
Institute on Drug Abuse, National Institutes of Health, Bethesda,
Maryland 20892, and Departments of Neurology and Neuroscience, Johns
Hopkins University, Baltimore, Maryland 21224
The activation of µ-opioid receptors in the nucleus accumbens
(Acb) produces changes in locomotor and rewarding responses that are
believed to involve neurons, including local
-aminobutyric acid
(GABA)ergic neurons. We combined immunogold-silver detection of an
antipeptide antiserum against the cloned µ-opioid receptor (MOR) and
immunoperoxidase labeling of an antibody against GABA to determine the
cellular basis for the proposed opioid modulation of GABAergic neurons
in the rat Acb. MOR-like immunoreactivity (MOR-LI) was localized
prominently to plasma membranes of neurons having morphological
features of both spiny and aspiny cells, many of which contained GABA.
Of 351 examples of profiles that contained MOR-LI and GABA labeling,
65% were dendrites. In these dendrites, MOR-LI was seen mainly along
extrasynaptic portions of the plasma membrane apposed to unlabeled
terminals and/or glial processes. Dually labeled dendrites often
received convergent input from GABAergic terminals and/or from
unlabeled terminals forming asymmetric excitatory-type synapses. Of all
profiles that contained both MOR and GABA immunoreactivity, 28% were
axon terminals. MOR-containing GABAergic terminals and terminals
separately labeled for MOR or GABA formed synapses with unlabeled
dendrites and also with dendrites containing MOR or GABA. Our results
indicate that MOR agonists could modulate the activity of GABA neurons
in the Acb via receptors located mainly at extrasynaptic sites on
dendritic plasma membranes. MOR ligands also could alter the release of GABA onto target dendrites that contain GABA and/or respond to opiate
stimulation.
Key words:
-aminobutyric acid;
striatum;
enkephalin;
opiate;
ultrastructure;
electron microscopy;
morphine